Document Detail


Vitamin B12 deficiency is the dominant nutritional cause of hyperhomocysteinemia in a folic acid-fortified population.
MedLine Citation:
PMID:  16197296     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Prevalence rates for folate deficiency and hyperhomocysteinemia have been markedly reduced following the introduction of folic acid fortification in the United States. We report the prevalence of hyperhomocysteinemia in a population of community-dwelling elderly Latinos in the post-folic acid fortification era. We measured homocysteine, total vitamin B12, holotranscobalamin, red blood cell folate, and serum creatinine in 1096 subjects aged > or =60 years. Hyperhomocysteinemia (>13 micromol/L) was observed in 16.5% of the subjects. The population attributable risk percentages for hyperhomocysteinemia were 29.7% for total B12 <148 pmol/L, 36.4% for holotranscobalamin <35 pmol/L, and 41.4% for creatinine >115 micromol/L. In contrast, the population attributable risk percentage for hyperhomocysteinemia was only 0.3% for red blood cell folate <365 nmol/L. We conclude that in the post-folic acid fortification era, low vitamin B12 status has become the dominant nutritional determinant of hyperhomocysteinemia. Steps to either reduce the prevalence of vitamin B12 deficiency or to identify and treat individuals with vitamin B12 deficiency could further reduce the prevalence of hyperhomocysteinemia.
Authors:
Ralph Green; Joshua W Miller
Related Documents :
9106106 - Treatment of cholestatic children with water-soluble vitamin e (alpha-tocopheryl polyet...
132216 - Local hyperalimentation of open wounds.
15664096 - Antioxidants inhibit fatty acid and glucose-mediated induction of neutral endopeptidase...
17961276 - Folate and vitamin b12: friendly or enemy nutrients for the elderly.
12612446 - Effects of iridoids on lipoxygenase and hyaluronidase activities and their activation b...
8204686 - Enrichment of selected serum fatty acids after a small oral dosage of (1-13c)- and (8-1...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Clinical chemistry and laboratory medicine : CCLM / FESCC     Volume:  43     ISSN:  1434-6621     ISO Abbreviation:  Clin. Chem. Lab. Med.     Publication Date:  2005  
Date Detail:
Created Date:  2005-10-03     Completed Date:  2005-12-02     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  9806306     Medline TA:  Clin Chem Lab Med     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  1048-51     Citation Subset:  IM    
Affiliation:
Department of Medical Pathology and Laboratory Medicine, University of California, Davis, Sacramento, CA 95817, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Aged, 80 and over
California / epidemiology
Folic Acid / administration & dosage*,  pharmacology*
Humans
Hyperhomocysteinemia / epidemiology,  etiology*
Middle Aged
Nutritional Status*
Prevalence
Risk Factors
Vitamin B 12 Deficiency / complications*,  epidemiology
Grant Support
ID/Acronym/Agency:
AG12975/AG/NIA NIH HHS
Chemical
Reg. No./Substance:
59-30-3/Folic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Hyperhomocysteinemia and response of methionine cycle intermediates to vitamin treatment in renal pa...
Next Document:  Homocysteine, folic acid and vitamin B12 in relation to pre- and postnatal health aspects.